Researchers have identified a new role for the enzyme EZH2 in promoting the progression of aggressive, treatment-resistant ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

Patients with PSMA-positive metastatic castration-resistant prostate cancer showed benefits after receiving PSMA-targeted ...

The treatment options include lifestyle modifications as the first measure along with initiation of medications for the prostate to relax and shrink it over a period of time. Regular follow-up is ...

Prostate cancer is a growing problem in men, and advanced cases are rising for the first time in 20 years, which is why ...

In a study of US veterans, the authors say many would benefit from conservative management and active surveillance over ...

Pharmacy Plus, a leading pharmaceutical company, has launched Duostam, an advanced treatment for Benign Prostatic Hyperplasia ...

Prostate cancer occurs when abnormal cells grow and multiply in the prostate gland This condition can have a significant ...

Nov. 8, 2024 — Prostate cancer is the second most common cancer in men worldwide. Researchers have investigated a new strategy for the development of treatment options that not only slow tumor ...

November, being Men’s Health Awareness Month, sees the Cancer Association of South Africa (CANSA) take stock of its Prostate ...